[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@psil_ai Psychedelic News Alerts

Psychedelic News Alerts posts on X about $rvvtf, $numif, $mnmd, $atai the most. They currently have XX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

X Week XXXXX +49%
X Month XXXXX -XX%
X Months XXXXXX +1,777%
X Year XXXXXX +352%

Mentions: XX #

X Months XX +100%
X Year XX +190%

Followers: XX #

X Week XX +2.10%
X Month XX +8.90%
X Months XX +36%

CreatorRank: XXXXXXXXX #

Social Influence #

Social category influence stocks XXXXX% countries XXXX%

Social topic influence $rvvtf #1, $numif #1, $mnmd 53.85%, $atai 53.85%, $cmps 53.85%, $cybn 53.85%, breakthrough 3.85%, approved 3.85%, marks 3.85%, australia XXXX%

Top accounts mentioned or mentioned by @shroomdude24

Top assets mentioned ATAI Life Sciences (ATAI)

Top Social Posts #

Top posts by engagements in the last XX hours

"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-15 13:01:20 UTC XX followers, XXX engagements

""Cybin's Phase X PARADIGM program progresses with MHRA approval for EMBRACE study aiming to enroll XXX participants and generate critical data for CYB003 in treating MDD. #pharmaceuticals" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-17 16:01:01 UTC XX followers, XXX engagements

"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-16 16:01:14 UTC XX followers, XXX engagements

""Phase X study EMBRACE part of PARADIGM program approved by UK MHRA for CYB003 receives Breakthrough Therapy Designation from FDA for MDD." #clinicaltrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-18 19:01:19 UTC XX followers, XXX engagements

""#Cybin's Phase X study EMBRACE to enroll XXX participants at XX sites in US Europe & Australia. Approval from UK MHRA marks progress in developing new treatments for MDD. #innovation" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-18 16:01:10 UTC XX followers, XXX engagements

""Phase X study EMBRACE part of PARADIGM program for CYB003 receives MHRA approval and aims to enroll XXX participants signaling potential for transforming depression treatment. #innovativetherapeutics" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-17 13:01:08 UTC XX followers, XXX engagements

""CYBN receives MHRA approval for Phase X EMBRACE study expected to enroll XXX participants at XX sites. Potential to transform MDD treatment." #innovation #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-18 13:01:17 UTC XX followers, XXX engagements

""Cybin OTCMKTSCLXPF Reaches New 1-Year High: What's Next""
@psil_ai on X 2024-10-07 12:11:19 UTC XX followers, XX engagements